首页> 外国专利> Peripheral blood miRNA markers for the diagnosis of non-small cell lung cancer

Peripheral blood miRNA markers for the diagnosis of non-small cell lung cancer

机译:外周血miRNA标记用于诊断非小细胞肺癌

摘要

The present invention discloses peripheral blood miRNA markers for the diagnosis of non-small cell lung cancer, wherein the peripheral blood miRNA markers are hsa-miR-1291, hsa-miR-1-3p, hsa-miR-214-3p, hsa-miR-375 or hsa-let-7a-5p. Five specific diagnostic markers suitable for diagnosing non-small cell lung cancer in Asian and Caucasian populations have been validated in a large number of samples, and they have higher population specificity compared to other previously reported miRNA markers. These five miRNA diagnostic markers have been proposed for the first time and have been shown to be more reliable than other miRNA molecular markers.
机译:本发明公开了用于诊断非小细胞肺癌的外周血miRNA标志物,其中外周血miRNA标记是HSA-miR-1291,HSA-miR-1-3p,Hsa-miR-214-3p,hsa- mir-375或hsa-let-7a-5p。 在大量样品中验证了适用于亚洲和高加索人群中非小细胞肺癌的五种特异性诊断标志物,与其他先前报告的miRNA标记相比,它们具有较高的人口特异性。 已经第一次提出了这五种miRNA诊断标记,并且已被证明比其他miRNA分子标记更可靠。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号